About Recombinetics
Recombinetics is a company based in Eagan (United States) founded in 2008.. Recombinetics has raised $65.54 million across 23 funding rounds from investors including NIH, HHS and National Cancer Institute. The company has 29 employees as of December 31, 2022. Recombinetics offers products and services including Gene Edited Swine Models and Precision Breeding Services. Recombinetics operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Eagan, United States
- Employees 29 as on 31 Dec, 2022
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.54 M (USD)
in 23 rounds
-
Latest Funding Round
$385 K (USD), Grant
Jun 01, 2024
-
Investors
NIH
& 2 more
-
Employee Count
29
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Recombinetics
Recombinetics offers a comprehensive portfolio of products and services, including Gene Edited Swine Models and Precision Breeding Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Custom models for preclinical research to advance healthcare innovations.
Breeding methods to improve animal health and sustainable farming practices.
Unlock access to complete
Unlock access to complete
Funding Insights of Recombinetics
Recombinetics has successfully raised a total of $65.54M across 23 strategic funding rounds. The most recent funding activity was a Grant round of $385 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Grant — $384,999
-
First Round
First Round
(16 May 2011)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Grant - Recombinetics | Valuation |
investors |
|
| Jun, 2023 | Amount | Grant - Recombinetics | Valuation |
investors |
|
| Jul, 2019 | Amount | Grant - Recombinetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Recombinetics
Recombinetics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Cancer Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cancer research is conducted and supported by the institute.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Recombinetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Recombinetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Recombinetics Comparisons
Competitors of Recombinetics
Recombinetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Recombinetics
Frequently Asked Questions about Recombinetics
When was Recombinetics founded?
Recombinetics was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Where is Recombinetics located?
Recombinetics is headquartered in Eagan, United States. It is registered at Eagan, Minnesota, United States.
Is Recombinetics a funded company?
Recombinetics is a funded company, having raised a total of $65.54M across 23 funding rounds to date.
How many employees does Recombinetics have?
As of Dec 31, 2022, the latest employee count at Recombinetics is 29.
What does Recombinetics do?
Recombinetics was founded in 2008 and is headquartered in Eagan, United States. Operations focus on the biotechnology sector, where proprietary gene repair and editing tools, including TALEN technologies, are applied. In agriculture, these are used to introduce natural traits into pigs and other livestock, aiming to improve health, welfare, and food safety. In biomedicine, large animal models for human disease research are created to support therapeutic and device development.
Who are the top competitors of Recombinetics?
Recombinetics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Recombinetics offer?
Recombinetics offers Gene Edited Swine Models and Precision Breeding Services.
Who are Recombinetics's investors?
Recombinetics has 3 investors. Key investors include NIH, HHS, and National Cancer Institute.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.